Background Niemann-Pick disease, type C (NPC) is a rare lysosomal storage disorder characterized by progressive neurodegeneration, splenomegaly, hepatomegaly, and early death. NPC is caused by mutations in either the NPC1 or NPC2 gene. Impaired NPC function leads to defective intracellular transport of unesterified cholesterol and its accumulation in late endosomes and lysosomes. A high frequency of Crohn disease has been reported in NPC1 patients, suggesting that gastrointestinal tract pathology may become a more prominent clinical issue if effective therapies are developed to slow the neurodegeneration. The Npc1 nih mouse model on a BALB/c background replicates the hepatic and neurological disease observed in NPC1 patients. Thus, we sought to characterize the gastrointestinal tract pathology in this model to determine whether it can serve as a model of Crohn disease in NPC1. Methods We analyzed the gastrointestinal tract and isolated macrophages of BALB/cJ cNctr-Npc1m1N/J (Npc1 −/− ) mouse model to determine whether there was any Crohn-like pathology or inflammatory cell activation. We also evaluated temporal changes in the microbiota by 16S rRNA sequencing of fecal samples to determine whether there were changes consistent with Crohn disease. Results Relative to controls, Npc1 mutant mice demonstrate increased inflammation and crypt abscesses in the gastrointestinal tract; however, the observed pathological changes are significantly less than those observed in other Crohn disease mouse models. Analysis of Npc1 mutant macrophages demonstrated an increased response to lipopolysaccharides and delayed bactericidal activity; both of which are pathological features of Crohn disease. Analysis of the bacterial microbiota does not mimic what is reported in Crohn disease in either human or mouse models. We did observe significant increases in cyanobacteria and epsilon-proteobacteria. The increase in epsilon-proteobacteria may be related to altered cholesterol homeostasis since cholesterol is known to promote growth of this bacterial subgroup. Conclusions Macrophage dysfunction in the BALB/c Npc1 −/− mouse is similar to that observed in other Crohn disease models. However, neither the degree of pathology nor the microbiota changes are typical of Crohn disease. Thus, this mouse model is not a good model system for Crohn disease pathology reported in NPC1 patients. 
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Background Niemann-Pick disease, type C (NPC) is a rare autosomal recessive disorder characterized by the accumulation of unesterified cholesterol and glycosphingolipids in the viscera and central nervous system [1] . Inherited loss-offunction mutations in genes encoding either NPC1 or NPC2 cause Niemann-Pick type C disease [1, 2] . These proteins are involved in the intracellular transport of cholesterol out of the endolysosomal compartment [3] . The endolysosomal accumulation of lipids and cholesterol initiates a pathological cascade that leads to cellular dysfunction and ultimately cell death. This cellular dysfunction and neuronal loss underlies the neurological signs and symptoms observed in patients with either NPC1 or NPC2 deficiencies. NPC1 patients demonstrate a wide phenotypic spectrum, both with respect to age of neurological disease onset and the individual signs/symptoms observed in each patient [1, [4] [5] [6] . The pathological mechanisms that contribute to disease progression have not been fully elucidated; however, one pathological process that likely contributes to the pathological cascade is inflammation. Increased levels of inflammatory biomarkers have been observed in both cerebrospinal fluid [7, 8] and blood [9, 10] , suggesting the involvement of an immune response in NPC pathology. Inflammatory markers have also been reported in tissues including the liver [11] , lungs [12, 13] , and brain [7, 14, 15] . Enteric neuropathology likely contributes to the progressive weight loss that occurs prior to death in the BALB/cJ cNctr-Npc1m1N/J (Npc1 −/− ) mouse [16] ; however, the chronic inflammation described in visceral tissues, including the gastrointestinal tract, may be a contributing factor. Notably, multiple clinical reports have shown an association between NPC1 disease and Crohn disease [17] [18] [19] [20] [21] .
Crohn disease is an inflammatory bowel disease (IBD) with a multifactorial etiology that includes interactions between genetic, environmental, and gastrointestinal tract microbiota [22, 23] . Genetic susceptibility occurs in individuals with genetic variants in NOD2, ATG16L1, TLR4, STAT3, and IL23R [22, 23] . Hypocholesterolemia appears to be associated with IBD, thus potentially implicating cholesterol and lipid metabolism as a contributing factor [24] . Recently, Schwerd et al. [21] had shown impaired bacterial clearance in monocytes/macrophages isolated from NPC1 patients due to impaired autophagosome function which inhibits NOD2-mediated bacterial handling. Defective autophagy is a common factor in IBD and may explain the reported cases of Crohn disease in NPC1 patients. Another similarity between NPC1 and Crohn disease is the activation of the TLR4 pathway [22, [25] [26] [27] . This activation leads to constitutive inflammation that contributes to disease progression in IBD. Thus, impaired autophagy and increased TLR4 signaling may underlie the reported clinical association of Crohn disease in NPC1 patients.
A number of NPC1 mouse models have been characterized. Homozygous BALB/cJ cNctr-Npc1m1N/J (Npc1 −/− ) mice die prematurely with progressive loss of Purkinje neurons and a striking decline in body weight after 7 weeks [11, 16] . The degree with which peripheral organ dysfunction contributes to morbidity and mortality is not well defined. Kapur et al. [16] had shown that Npc1 −/− mice exhibit enteric neuronal defects and histological alterations in intestinal mucosa; however, the degree to which this NPC1 mouse model recapitulates the IBD reported in NPC1 patients has not been investigated until now. Given that gastrointestinal dysfunction may contribute to the weight loss and morbidity, we characterized gastrointestinal tract mucosal pathology, macrophage function and the gastrointestinal tract microbiota in the Npc1 −/− mouse.
Methods

Mice and Animal Husbandry
Mice were housed under standard conditions and given free access to food and water. All animal work conformed to the National Institutes of Health guidelines and was approved by the Eunice Kennedy Shriver National Institute of Child Health and Human Development Institutional Animal Care and Use Committee. Heterozygous BALB/ cNctr-Npc1m1N/J (Jackson Laboratory, Bay harbor, ME, USA), Npc1 +/− , mice were intercrossed to obtain control (Npc1 +/+ ) and mutant (Npc1 −/− ) littermates. Pups were weaned 3 weeks after birth and subsequently had free access to water and NIH#31 mouse diet (Envigo, Cambridgeshire, UK). PCR genotyping was performed using tail DNA [11] . Mice were killed at 3, 5, 7, and 9 weeks of age.
Western Blotting
Proteins extracted from mouse tissues were separated on 4-12% NuPAGE gels (Life Technologies, Carlsbad, CA, USA), dry-transferred to nitrocellulose membranes, blocked with 2% BSA in PBS-Tween 0.1%, and probed with anti-CD68 (Bio-Rad, Hercules, CA, USA), anti-iNOS (Millipore, Darmstadt, Germany), and anti-MPO (R&D, Minneapolis, MN, USA). Secondary antibodies used were HRP antimouse, anti-rat, or anti-rabbit (Sigma-Aldrich, St-Louis, MO, USA). Proteins were detected by chemiluminescence with the ChemiDocXRSsystem (Bio-Rad Laboratories, Hercules, CA, USA). Densitometric analyses were performed using Image Lab 4.1 software (Bio-Rad Laboratories, Hercules, CA, USA).
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Cholesterol Assay
Cholesterol content was determined by extracting sterols from tissue samples as previously described by Picache et al. [28] . Sample analysis was performed using a laser diode/thermal desorption source (S-960 series, Phytronix Technologies Inc., Québec, Canada) coupled to an AB-Sciex TripleTOF 5600+ mass spectrometer (Redwood City, CA, USA).
RNA Extraction and RT-qPCR
Total RNA was extracted from mouse tissue using TRIzol reagent (Life Technologies, Carlsbad, CA, USA), followed by purification with Qiagen RNeasy Mini Columns (Qiagen, Hilden, Germany). For gene expression analysis by realtime qPCR, the quality and quantity of RNA were assessed using NanoDrop (Thermo Scientific, Inc., Pittsburgh, PA, USA). One microgram of total RNA was reverse-transcribed to obtain cDNA using a high-capacity cDNA archive kit, according to the manufacturer's instructions (Thermo Scientific, Inc., Pittsburgh, PA, USA). The following TaqMan assays were used to assess the expression level of: Tnf (Mm00443258_m1), Il1b (Mm00434228_m1), TnfR1 (Mm00441883_g1), and Actb (4352341E). Amplifications were performed in 96-well plates with an Applied Biosystems 7300 real-time PCR system. Each sample was analyzed in triplicate, using 50 ng of total cDNA for each reaction.
Microbiota Analysis
The stool samples were collected from 4 Npc1 +/+ and 4
Npc1
−/− mice at 3, 5, 7, and 9 weeks of age. Mice were individually housed, and stool samples were stored at -80 °C until used. Microbial DNA was isolated using the QiAmp DNA stool kit (Qiagen, Hilden, Germany) as described by the manufacturer. Multiple replicate PCRs were performed using the fecal DNA sample. Each 100 μL reaction contained 100 ng of template DNA, 0.3 μM of the forward universal bacterial primer 8F (5'-AGA GTT TGA TCC TGG CTC AG-3'), 0.3 μM of the reverse universal primer 1525r (5′-AAG GAG GTG WTC CARCC-3′), 1U Taq DNA Polymerase (Roche, Basel, Switzerland), 1X amplification buffer, and 0.3 mM of each dNTP. Cycling conditions were 94 °C for 2 min, followed by 20 cycles of 94 °C for 15 s, 55 °C for 30 s, and 72 °C for 2 min, and a final elongation step at 72 °C for 10 min. Replicate PCRs were pooled and purified using the QiAmp DNA mini kit (Qiagen, Hilden, Germany). All sequence reads with less than 97% similarity with the known organisms in the Greengenes database [29] were not considered for further analysis. Representative sequences for each operative taxonomic unit were assigned to different bacterial taxonomic levels by using Greengenes database as previously described using QIIME [30] .
Macrophage and In Vitro Infection
Peritoneal macrophage was isolated as previously described [31] and maintained in RPMI (Life Technology, Carlsbad, CA, USA), l-glutamine (4 mM), and sodium pyruvate (110 µg/ml) (Life Technologies, Carlsbad, CA, USA) and supplemented with 10% heat-inactivated, low-endotoxin-unit FBS (Omega Scientific, Offenburg, Germany) prior to infection. Cells were detached from plates, counted, and plated (onto a 12-well plate at a density of 10 5 cells per well). The following day, E. coli grown to an optical density (OD 600nm ) of 0.3 were used to infect the cells or purified MDP or LPS was used to stimulate the cells according to standard procedures. Immediately before infection, cells were washed twice with PBS and the medium containing the bacteria was added. Macrophages and bacteria were incubated for 60 min and then washed twice, after which medium containing gentamicin (20 µg/ml) was added for 1 h. Cells were washed and lysed with 1% Triton X100-PBS (t = 2, 4, 8, or 16 h). Bacteria in lysis buffer were serially diluted in PBS and plated onto LB agar plates. Growth was recorded 48-72 h later by direct counting of the bacteria colonies.
Macrophage was grown in 8-well TC Lab-Tek Chamber Slides (Thermo Fischer Scientific, MA, USA) for 24 h. Cells were then washed with PBS, fixed with 4% paraformaldehyde for 10 min at + 4 °C, and permeabilized with BD Perm/ Wash buffer (BD Bioscience, San Diego, CA, USA). Nonspecific binding was blocked with 10% normal goat serum diluted into 2% BSA/PBS for 30 min at room temperature. Anti-NLRP3-488 (1:50, Biolegend, San Diego, CA, USA), anti-Cleaved caspase-1 (1:100, Biolegend, San Diego, CA, USA), and anti-Iba1 (1:200, Wako, Richmond, VA, USA), were diluted in 10% normal goat serum with 2% BSA/PBS and applied for 30 min at 37 °C followed by overnight incubation at 4 °C. Secondary antibodies were diluted 1:1000 in 10% normal goat serum with 2% BSA/PBS and kept for 1 h at room temperature in the dark. After washing, samples were mounted with Mowiol (EMD-Millipore, Darmstadt, Germany). Images were recorded using a Zeiss Axioplan microscope and the ZEN2 Zeiss application software (Zeiss, Oberkochen, Germany).
Statistical Analysis
Statistical analyses were performed using GraphPad Prism 5 software (San Diego, San Diego, CA, USA). p values < 0.05 were considered statistically significant.
Results
Gastrointestinal Tract Pathology
In order to evaluate the potential clinical association between NPC1 and Crohn disease, we characterized the degree of inflammatory pathology found in the digestive tract of Npc1 −/− mice. Hematoxylin-eosin-stained sagittal sections of the digestive tract demonstrated disruption of normal gastric architecture and intracellular storage in all layers of the gastric epithelium in Npc1 mutant mice relative to control mice (Fig. 1a-f ). In the Npc1 −/− mice, vesicles were visible along the width of the gastric epithelium but not in the muscular layer, suggesting that gastric myoblasts are less affected by the loss of NPC1 than the epithelial cells. Parietal cell and chief cell sizes were not affected, and no obvious intracellular storage was noted; however, a disorganization of the mucosal layer was observed. The observed storage is associated with increased levels of cholesterol measured in the stomach tissue of Npc1 −/− mice (10.93 ± 1.28 vs. 20.24 ± 1.56 µg of total cholesterol per mg of protein in Npc1 +/+ mice compared to Npc1 −/− mice, respectively, p = 0.01). None of the analyzed inflammation makers were significantly increased in stomach tissue (Fig. 1g) .
Consistent with what has been reported in other mouse models with gastrointestinal inflammation [32, 33] , the Npc1 −/− mice exhibited a significantly shorter gastrointestinal tract length than the control mice at 9 weeks of age, when normalized for mouse mass [ Fig. 2a (ileum) , b (colon)]. These changes were not observed at 5 and 7 weeks of age. At 9 weeks of age, we also observed a significant increase in inflammation biomarkers: CD68, MPO, iNOS (Fig. 2c) , and increased mRNA expression of TnfaR1 (Fig. 2d) in Npc1 −/− gastrointestinal tract tissue. We did not observe altered gene expression of either Tnfα or Il1b, two other inflammatory markers (Fig. 2d) .
Given that no inflammation markers and no change in gastrointestinal tract length were measured at earlier time points, we used the scoring system developed by Erben et al. [34] to quantify the degree of pathological changes in the gastrointestinal tract of 9-week-old Npc1 −/− . This evaluation includes characterization of inflammatory cell infiltrates (severity and extent), epithelial change (hyperplasia, loss of goblet cell, cryptitis, and crypt abscess formation), and mucosal architecture (erosion, ulceration, granulation tissue, irregular crypts, crypt loss, villous blunting). Data comparing control and mutant mice are provided in Table 1 . Minimal abnormalities were observed in Npc1 +/+ animals. These included mucosal inflammation and leukocyte depletion, in a small number of animals. A similar degree of mucosal inflammation and leukocyte depletion was observed in tissue from Npc1 mutant mice. In contrast, the frequency of crypt abscesses (Fig. 3a, Table 1 ) was significantly increased in both ileum and colonic tissue from Npc1 −/− mice. Specifically, 6/14 and 5/14 Npc1 −/− mice had crypt abscesses in the ileum and colon, respectively (p < 0.05), whereas none were observed in controls. Crypt abscesses were observed in both the ileum and colon in two mutant animals. Although the total score was elevated in Npc1 −/− mice for both the ileum (0.73 ± 0.28 vs. 2.79 ± 0.70) and colon (0.27 ± 0.21 vs. 1.07 ± 0.40), only the ileum difference was significant (p = 0.02 and p = 0.15, respectively). In an acute Crohn disease mouse model, such as dextran sulfate sodium (DSS) or in genetic models such as the Tnf ΔARE/ΔARE or SAMP1/Yit [35] , a major erosion of the mucosal architecture is observed in association with the crypt abscesses and ulceration with 100% penetrance [36] . The observed pathological changes observed in the Npc1 mutant mice are substantially less than these mouse models of Crohn disease.
Macrophage Antibacterial Function
Impaired antibacterial autophagy has been implicated in Crohn disease [22, 23, 37, 38] , and impaired bacterial autophagy and bacterial killing have been reported in macrophages isolated from NPC1 subjects [21] . Thus, we evaluated the bactericidal activity of macrophages isolated from Npc1 −/− mice. We isolated peritoneal macrophages at 5, 7, and 9 weeks of age and evaluated the expression of two key inflammation markers, caspase-1 and NLRP3 by Western blot and indirect immunofluorescence (ICC). Peritoneal macrophages deficient for Npc1 showed increased levels of active caspase-1 as early as 5 weeks of age, followed by increased levels of NLRP3 at 7 and 9 weeks when Table 1 , n > 6; U test, *p < 0.01 (Fig. 4a ). An increase in the expression of NLRP3 and cleaved caspase-1 in Npc1 −/− macrophages as assessed by ICC compared to Npc1 +/+ (Fig. 4b, c) was also observed. We elected to perform further experimental analyses on macrophages isolated from mice at 7 weeks of age, the earliest time macrophages showed activation directly after isolation.
To characterize the immune response toward bacterial products, we isolated macrophage from 7-week-old Npc1
−/− mice peritoneal lavage (PLM), and we found no significant difference in basal expression levels of Tnf (p PLM = 0.48) in response to purified muramyl dipeptide (MDP) (1.67 ± 0.61 vs. 6.82 ± 3.71, p PLM = 0.16, n = 6) (Fig. 4d) . This is consistent with the prior observation made in human macrophages where no difference was observed after MDP stimulation [21] . This also suggests that the environment where the macrophages come from does not modulate the ability to respond to bacterial stimuli. However, a significant increase in Tnf expression was seen in macrophages from Npc1 −/− mice in response to lipopolysaccharides (LPS) compared to macrophages from Npc1 +/+ mice (1451.46 ± 21.51 vs. 1996.00 ± 133.2, p PLM = 0.03, n = 6/group) (Fig. 4d) . This finding is also consistent with what has been previously reported for human cells [21, 26] . Hence, macrophages from Npc1 −/− mice appear to behave similarly to human macrophages from NPC1 patients with respect to stimulation of their immune response.
Assessments of phagocytic activity using the non-pathogenic Escherichia coli were then tested in peritoneal macrophages. These cells showed a similar phagocytic activity independent of the genotype (Fig. 4e) . However, the intracellular bacterial survival was significantly increased in the Npc1 −/− cells compared to Npc1 +/+ at 8 and 16 h (Fig. 4e) . These results, in addition to the well-characterized autophagy defect in NPC1 [25, 39] , highlight an abnormal innate immune response and correlate with the chronic inflammation reported in NPC1 patients with Crohn disease and the inflammation in the Npc1 −/− mice [7, 11] . Taken together, these results recapitulate the observations made using human cells [21] and validate the use of these mice to study the Crohn disease-like phenotype with the Npc1 −/− background specifically in macrophages.
Intestinal Microbiota
Altered intestinal microbiota is known to play a role in Crohn disease, and cholesterol is a known microbiota modifier [40] [41] [42] . In addition, since the defective bacterial clearance in Crohn disease has been associated with modification of the intestinal microbiota, we then evaluated the microbiota over the course of the disease in the mouse model of NPC1 [43] . 16S rRNA from the stool samples of Npc1 −/− and Npc1 +/+ at 3, 5, 7, and 9 weeks of age (n = 4/ group) was analyzed. No apparent differences were seen by principal component analysis between the bacterial groups independent of age or genotype of the mice (Fig. 5a ). In addition, no significant diversity change was seen over time between the Npc1 +/+ or Npc1 −/− mice. The two main populations firmicutes and bacteroidetes do not change significantly over the course of the disease; however, there was a trend toward enrichment of proteobacteria (p 3W = 0.69, p 5W = 0.3, p 7W = 0.34, p 9W = 0.2; Fig. 5a, b) and cyanobacteria (p 3W = 1, p 5W = 1, p 7W = 0.34, p 9W = 0.06; Fig. 5a,  b ). Analysis at the class level revealed that the increase in proteobacteria was mainly due to the increase in epsilonproteobacteria (Fig. 5c ) with no significant variation in the levels of alpha-, beta-, delta-, or gamma-proteobacteria. Epsilon-proteobacteria present in our analysis were assigned to two main organisms: Helicobacter and Campylobacter (Fig. 5d ). Analysis at the species level suggests Helicobacter enrichment is driven by H. hepaticus since no change in H. pylori was measured. H. bilis, H. rodentium, H. typhlonius, and H. trogontum were not identified in the 16S reads. Hence, the significantly increased level of cholesterol in the tissues may explain the increase in these two closely related epsilon-proteobacteria. The other bacterial population that exhibited an increased trend over time in Npc1 −/− mice was Cyanobacteria (Fig. 5b) . To date, these bacteria have not been associated with inflammatory bowel diseases or lysosomal storage diseases although they have been associated with gastroenteritis after consumption of contaminated water [44] .
Discussion
The Npc1
−/− mouse model has proven to be an extremely useful tool for studying the pathology of NPC1 and developing therapeutic interventions, as it emulates the neurodegeneration and other aspects of the human disorder. We were interested in determining whether the null Npc1 mutant mouse would also be useful in understanding the reported association between NPC1 and Crohn disease [17] [18] [19] 21] . Although we demonstrated several pathological features that are consistent with Crohn disease, the Npc1 −/− gastrointestinal tract pathology is minimal and does not adequately model Crohn disease. The only notable pathology we observed, consistent with Crohn disease, was an increase in the number of animals with crypt abscesses. We did not observe immune cell infiltration that is typical in other Crohn disease models. We also did not observe microbiota changes that have been associated with Crohn disease. One limitation of this study was the use of BALB/c mice, which are more resistant to colitis than C57/BL6 mice, the more commonly used mouse strain for modeling IBD [36] . C57/BL6 Npc1 −/− mice manifest severe liver and spleen
3
pathology that results in an early non-neurological death [45] . Pathological analysis of the gastrointestinal tract has not been reported in this model. Although histopathological changes were minimal and microbiota changes were not significant, we did observe increased expression of inflammatory biomarkers similar to what has been reported in chemically induced or genetic mouse models of Crohn disease [23, 34, 36, [46] [47] [48] [49] [50] . We also demonstrate that Npc1 −/− peritoneal macrophages, similar to NPC1 patient macrophages and genetic models of Crohn disease [20, 24, [54] [55] [56] , show an enhanced response to TLR4 induction and a defect in antibacterial autophagy and clearance. Given the multifactorial nature of Crohn disease, it is possible that additional genetic or environmental factors are necessary for manifestation of Crohn disease in this Npc1 mutant mouse model.
Although it may be a better model of ulcerative colitis, DSS has frequently been used to model Crohn disease [36] . Treatment of Npc1 mutant mice could potentially provide data, showing that NPC1 disease predisposes to the development of Crohn disease. However, the mouse model of NPC1 used in this work does not allow the use of this protocol, which generally uses 7-8-week animals treated for 7 days with 2.5-5% DSS. At this age, the Npc1 mutant mice already display significant pathology and are losing weight, which is an indicator of colitis [36] . Consideration should be given to evaluating DSS sensitivity in less severe NPC1 mouse models, such as with p.D1005G [51] or p.I1061T [52] missense mutations on the C57BL6 background.
To our knowledge, this is the first study evaluating microbiota in Npc1 −/− mice. We observed increases in epsilonproteobacteria, specifically Helicobacter and Campylobacter. These two bacterial classes are well documented as proinflammatory organisms in mice and humans [53] [54] [55] [56] ; however, at the species level we found that the Helicobacter enrichment was due to an increase in H. hepaticus rather than H. pylori. In addition, it has been reported that cholesterol favors the growth of Helicobacter in vitro and could participate in the enrichment of those populations [57] . The other bacterial population that exhibited an increased trend over time in Npc1 −/− mice was Cyanobacteria. To our knowledge, these Cyanobacteria have not been associated with inflammatory bowel diseases or lysosomal storage diseases. Whether this finding has pathological implications is unknown. Colonization by specific bacteria can potentiate basal inflammation levels. Thus, differences in gastrointestinal microflora may influence the penetrance of Crohn disease in NPC1 patients. Intestinal inflammation has been shown to be promoted by facultative pathogens such as segmented filamentous bacteria via an IL17-dependent mechanism [60] . In this study, we found that levels of segmented filamentous bacteria do not differ between the gastrointestinal microflora of Npc1 mutant and control mice, and IL17 levels are not altered in NPC1 disease [11, 15] . In contrast, we observed an enrichment of Helicobacter. This enrichment may be explained by prior observations that cholesterol favors the growth of Helicobacter in vitro [58] . Desquamation of epithelial cells with increased intracellular cholesterol might increase intraluminal cholesterol levels, thus favoring the growth of Helicobacter. Alternatively, in NPC1 the lysosomal storage of unesterified cholesterol has been associated with increased activation of the TLR4-STAT1 pathway in myeloid cells [26] . This could lead to the secretion of proinflammatory cytokines that alter the microbiome creating a favorable niche for Helicobacter [59] .
This work suggests that the association of Crohn disease with NPC1 may not simply be due to loss of NPC1 function, but rather may represent a more complicated interaction with other genetic factors and the environment. Additional work will be needed to elucidate these contributing factors.
